FY2025 EPS Estimates for VERA Decreased by Cantor Fitzgerald
Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 EPS estimates for Vera Therapeutics in a note issued to investors on Tuesday, March 4th. Cantor Fitzgerald analyst P. Stavropoulos now expects that the company will post earnings of ($2.53) per share for the year, down from their […]
Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) – Equities research analysts at Cantor Fitzgerald cut their FY2025 EPS estimates for Vera Therapeutics in a note issued to investors on Tuesday, March 4th. Cantor Fitzgerald analyst P. Stavropoulos now expects that the company will post earnings of ($2.53) per share for the year, down from their […]
